These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8456815)

  • 1. Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfecta.
    Marini JC; Bordenick S; Heavner G; Rose S; Chrousos GP
    Am J Med Genet; 1993 Jan; 45(2):261-4. PubMed ID: 8456815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The growth hormone and somatomedin axis in short children with osteogenesis imperfecta.
    Marini JC; Bordenick S; Heavner G; Rose S; Hintz R; Rosenfeld R; Chrousos GP
    J Clin Endocrinol Metab; 1993 Jan; 76(1):251-6. PubMed ID: 8421094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
    Marini JC; Hopkins E; Glorieux FH; Chrousos GP; Reynolds JC; Gundberg CM; Reing CM
    J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteogenesis imperfecta: clinical, cephalometric, and biochemical investigations of OI types I, III, and IV.
    Jensen BL; Lund AM
    J Craniofac Genet Dev Biol; 1997; 17(3):121-32. PubMed ID: 9338855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
    Land C; Rauch F; Travers R; Glorieux FH
    Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of poor linear growth in a patient with osteogenesis imperfecta type III.
    Robinson RF; Long LD; Mahan JD
    Clin Ther; 2004 Oct; 26(10):1680-3. PubMed ID: 15598484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High growth hormone levels in clinically short stature children.
    Awan TM; Sattar A; Khattak IG
    J Ayub Med Coll Abbottabad; 2006; 18(2):29-33. PubMed ID: 16977810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency.
    Loche S; Bizzarri C; Maghnie M; Faedda A; Tzialla C; Autelli M; Casini MR; Cappa M
    J Pediatr; 2002 Apr; 140(4):445-9. PubMed ID: 12006959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine aspects of growth deficiency in OI.
    Marini JC; Bordenick S; Chrousos GP
    Connect Tissue Res; 1995; 31(4):S55-7. PubMed ID: 15612383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation between growth hormone provocative test results and subsequent growth rates during growth hormone therapy.
    Bell JJ; Dana K
    Pediatrics; 1998 Aug; 102(2 Pt 3):518-20. PubMed ID: 9685456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience.
    August GP; Julius JR; Blethen SL
    Pediatrics; 1998 Aug; 102(2 Pt 3):512-6. PubMed ID: 9685455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
    Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
    Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteogenesis imperfecta in childhood: perceived competence in relation to impairment and disability.
    Engelbert RH; Gulmans VA; Uiterwaal CS; Helders PJ
    Arch Phys Med Rehabil; 2001 Jul; 82(7):943-8. PubMed ID: 11441383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of growth hormone secretion and action in growth-retarded children with juvenile chronic arthritis (JCA).
    Tsatsoulis A; Siamopoulou A; Petsoukis C; Challa A; Bairaktari E; Seferiadis K
    Growth Horm IGF Res; 1999 Apr; 9(2):143-9. PubMed ID: 10373347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
    Korpal-Szczyrska M; Dorant B; Kamińska H; Birkholz D; Niedźwiecki M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total body bone mineral and tartrate-resistant acid phosphatase levels in type I and III osteogenesis imperfecta.
    Rico H; Revilla M; Iritia M; Arribas I; Fernando Villa L
    Miner Electrolyte Metab; 1991; 17(6):396-8. PubMed ID: 1823391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteogenesis imperfecta: fibronectin in dentin matrix.
    Lukinmaa PL; Ranta H; Vaheri A
    J Craniofac Genet Dev Biol; 1988; 8(1):75-82. PubMed ID: 3062036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Somatomedin activity and growth hormone secretion in children with idiopathic growth retardation (author's transl)].
    Carrascosa A; Prevot C; Evain D; Czernichow P; Rappaport R
    Arch Fr Pediatr; 1980 Oct; 37(8):515-9. PubMed ID: 7447606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.